In severe COVID-19, we observed significant imbalances in HIF-1α/HIF-3α and HIF-2α/HIF-3α ratios, suggesting a breakdown in hypoxic adaptation and the onset of pathological inflammation. This evidence concerns the gene HIF1A and COVID-19.